Label reference · Respiratory & allergy
Trelegy Ellipta (Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate) Powder — label reference
DailyMed · Retrieved 2026-10-13
Trelegy Ellipta is listed in DailyMed as powder. Active ingredients: fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. This reference records product facts and version 15; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- Trelegy Ellipta
- Generic product name
- fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
- Active ingredient
- FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
- Dosage form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- SPL author / labeler
- GlaxoSmithKline LLC
- SPL version
- 15
- Published on DailyMed
- 2026-09-02
- SPL effective date
- 2023-06-02
- SPL set ID
- b5a81d5a-4648-4c7a-951d-33c014a63c7e
Product identity
Product name: Trelegy Ellipta
Generic name: fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
Active ingredients: FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
Dosage form: POWDER
Route: RESPIRATORY (INHALATION)
Label version
DailyMed published this record on 2026-09-02. SPL version: 15. Set ID: b5a81d5a-4648-4c7a-951d-33c014a63c7e. The SPL effective date is 2023-06-02.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-09-02. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.